Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.
about
Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionMitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseRole of family history for Alzheimer biomarker abnormalities in the adult children studyPolymorphic variation in cytochrome oxidase subunit genes.Diffusion tensor MRI as a biomarker in axonal and myelin damage.Amyloid burden and neural function in people at risk for Alzheimer's Disease.Cognitive activities and cognitive performance in middle-aged adults at risk for Alzheimer's disease.Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.The Alzheimer's disease mitochondrial cascade hypothesisRecent advances in imaging Alzheimer's disease.Structural imaging in early pre-states of dementia.Effects of hypoperfusion in Alzheimer's disease.Family history and APOE-4 genetic risk in Alzheimer's disease.Effects of ApoE4 and maternal history of dementia on hippocampal atrophyProgressive regional atrophy in normal adults with a maternal history of Alzheimer disease.Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease.Structural brain changes in normal individuals with a maternal history of Alzheimer's.Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease.Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer's disease.Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Using biomarkers to improve detection of Alzheimer's disease.FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Cognitively normal individuals with AD parents may be at risk for developing aging-related cortical thinning patterns characteristic of ADFamily history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adultsAmyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parentsAlzheimer disease family history impacts resting state functional connectivity.A diffusion model analysis of episodic recognition in preclinical individuals with a family history for Alzheimer's disease: The adult children study.Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.Maternal family history is associated with Alzheimer's disease biomarkersAbnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment.Multiple Imputation of a Randomly Censored Covariate Improves Logistic Regression Analysis.Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohortInsulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain.
P2860
Q26865358-FDA7C0FB-225D-4048-A184-0034E51A2B78Q28280353-F61FA3C4-09D9-4B44-B678-78260F9F9320Q28383467-5449EDE5-2B3D-4CFA-AE0E-BA4F8C56C329Q30435387-CE84BBBD-35E0-4B2A-95DA-E523FC071BE5Q30814256-6CEF0E2A-6FB0-4052-BE2E-489DD4B584FCQ33599047-564047AF-1B93-4780-8B1B-6FFC3BDFF4C7Q33643289-800117F7-997E-46A4-AE11-49B78C2459F7Q33778436-AE7A1877-1C42-48F6-8D3C-E7168BD15F96Q33783000-921BC5F1-6F48-410C-95A9-3BDC85A857DAQ33905871-3416197F-8FFE-4480-BE2E-AF151A358434Q33946440-3958897F-6999-4217-878B-AABBD1278838Q33967561-6D2C4F15-8916-42B8-BDFE-47AF7BB4C5AFQ34039966-E4383B52-7C3A-4436-9CFD-50148206E434Q34167647-7598B503-60C4-421A-BF3A-CD150A7E7A66Q34440832-FEB32517-184C-478B-84D7-CC1CDA1C1C5EQ34647037-98C8AAF4-169D-4CA3-A019-6EF0B60DC41AQ34683758-30673EA7-7093-41BF-B2A7-8766D63D7451Q34989844-648A9F43-8836-4F3D-8F9F-00618D7517B5Q35046339-BDDB3256-E754-47B8-A851-AD9FAAF6A795Q35161146-3D73CACD-3B56-4DA8-B19C-E90348E6C2A0Q35226739-8592428F-43C5-4AB2-BBEA-192054ADF7B4Q35229601-0A2E093C-9175-4A85-BA69-9400403EC8BCQ35533115-59A658A6-F1FF-499B-917A-EA8D00DC4767Q35792038-BDC84FA5-1F0F-4DA5-B311-F76D3D5C97FCQ35795672-6DE5EA3D-0436-416F-A20A-6878B515BCC9Q35898628-31CB5EBA-78C2-4E9B-BE44-385398C23999Q35916588-43F243FE-4B97-4A95-B860-A25FD393AE89Q35958359-986AC04F-E9EA-4109-86AD-77DD78E170FDQ35980976-030725F5-B81D-4D7D-ACF9-F82F4200818BQ35985990-A23A9665-FEE4-4919-8F17-A2D1DB8325DAQ36110188-7D0FFAC7-9D65-4DF2-9071-10C31D7125EDQ36375531-FEF1D427-80B3-4EA5-858B-98596CA25F94Q36484068-D662E1D7-23C8-434D-88B9-607C8D694977Q36687669-F52DC590-4347-478A-B4DF-9626371EDB54Q36717013-11B75B08-FB97-4EAD-8CBB-AD6A4DB7DA12Q36911784-46E96B5B-E2DE-41D7-B20E-D47BBE43C0BAQ37305738-D676D453-B2EC-4DCB-9174-88EF5BF93623Q37334389-5C02504A-7220-4831-A63B-DFD3AB3792E4Q37343162-968A09B3-C0E5-4430-AD7D-8DF0E0E1F594Q37351380-621F225A-21A5-4E11-864B-8CA446A4EB65
P2860
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Reduced gray matter volume in ...... history of Alzheimer disease.
@ast
Reduced gray matter volume in ...... history of Alzheimer disease.
@en
type
label
Reduced gray matter volume in ...... history of Alzheimer disease.
@ast
Reduced gray matter volume in ...... history of Alzheimer disease.
@en
prefLabel
Reduced gray matter volume in ...... history of Alzheimer disease.
@ast
Reduced gray matter volume in ...... history of Alzheimer disease.
@en
P2093
P2860
P1433
P1476
Reduced gray matter volume in ...... history of Alzheimer disease.
@en
P2093
E D Vidoni
R H Swerdlow
P2860
P304
P356
10.1212/WNL.0B013E3181C918CB
P407
P577
2010-01-01T00:00:00Z